Traws Pharma, Inc. — Director's Dealing 2013

Aug 1, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-30

Reporting Person: BANSAL AJAY (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-07-30	Common Stock	C	23785	—	Acquired	43846	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-07-30	Series B Convertible Preferred Stock	$	C	28181	Disposed		Common Stock (23785)	Direct

Footnotes

F1: Includes 680 shares held jointly with spouse.

F2: The Series B Convertible Preferred Stock converted into Common Stock on a 0.85-for-1 basis and had no expiration date.

F3: Includes 806 shares held jointly with spouse.